Searched for
PHARMACEUTICALS GST
Nifty upside limited, but stock-specific opportunities remain: Pramod AmtheIndian equities face headwinds from inflation and monsoon uncertainty, yet opportunities exist. Pramod Amthe of InCred Capital highlights s...- Don't wait for FIIs: Nippon MF CIO Sailesh Raj Bhan on why market will rise before foreign money returnsIndian equities offer rare discounts for investors. Nippon India Mutual Fund's Equity CIO, Sailesh Raj Bhan, advises accumulating world-cla...
- Why a Rs 72,000 crore fund manager refuses to chase defence rally nowICICI Prudential's Mittul Kalawadia advises caution on current market valuations. He notes that future growth is already factored into stoc...
- India's productivity gap with China widens despite strong GDP growth; manufacturing leap still missing: ReportIndia's labour productivity gap with China has widened significantly since 2000, despite strong economic growth. The country has yet to ach...
- 12 years of PM Modi: Bold reforms, decisive decisions and political turning pointsAfter 12 years at the helm, Prime Minister Narendra Modi reflects on a transformative journey filled with key reforms that have altered Ind...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- India’s 'China-plus-one' push needs tax ease and fast-track FTAs with developed nations: Arvind VirmaniIndia must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...
- India’s realty equity inflows hit record $30.7 billion between 2024-Q1 2026Between 2024 and early 2026, India’s real estate landscape witnessed an astonishing influx of over $30 billion in equity capital, showcasin...
- IMEC momentum to boost Karnataka exports amid global trade disruptionsBengaluru exporters are poised to thrive as the India-Middle East-Europe Economic Corridor gains traction. This innovative route presents a...
- GST Council should consider lowering tax on household insecticides to 5 pc: EY-HICA reportA new report recommends lowering the Goods and Services Tax on household insecticides. The current 18 percent rate could be reduced to 5 pe...
- Why smallcap funds are still a buy: A long-term strategy from Aditya KhemaniSmallcap valuations seem high but underlying fundamentals have improved. Aditya Khemani of Invesco Mutual Fund sees this as a structural sh...
- Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
- Corrugated box manufacturers warn of severe cost surge, call for price revision and policy supportIndia's corrugated box makers are in crisis. Kraft paper prices have jumped 15-20 percent. Other materials like gum and ink are up 30-40 pe...
- Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
- Drug, medtech companies fear GST changes may squeeze fundsPharma and medtech sectors are concerned about upcoming Goods and Services Tax changes. They anticipate higher operating costs and working ...
- Pharma firms tide over GST impactPharma firms had seen their revenues negatively impacted in the first quarter due to destocking ahead of the GST implementation.
- Expect lower Q1 sales in India due to GST implementation: DRLOverall, DRL is optimistic of delivering a better performance in 2017-18 compared to the previous one, having weathered what it called a 'p...
- Department of Pharmaceuticals sets up facilitation cell to help firms shift to GSTIn order to help and support the pharmaceutical industry in ensuring smooth and successful rollout of GST, a facilitation cell is hereby co...
- Pharma market grows 7% in May, beats pre-GST fearsThere were fears that the market may witness a lower growth in May before GST kicks in, as there would be ostensible attempts to maintain a...
Load More
